Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

5838.5000 71.00 (1.23%)

NSE Nov 13, 2025 10:55 AM

New 52W High today

Volume: 74,072

Alkem Laboratories Ltd.

10 Aug 2023

5838.50

1.23%

Alkem Labs (SELL): International sales fuel growth; margin recovery positive

Sell: Alkem Laboratories Ltd.

Target

BOB Capital Markets Ltd.

Q1 revenue/EBITDA a beat as international business outperformed; adj. PAT growth in line with consensus at 65% QoQ

Alkem Laboratories L.. has an average target of 5463.50 from 2 brokers.